Know Cancer

or
forgot password
  • cancer clinical trials in kalispell, MT

  • Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Glacier Oncology PLLC
    Kalispell, Montana 59901
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Glacier Oncology PLLC
    Kalispell, Montana 59901
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Malignant Mesothelioma
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Glacier Oncology, PLLC

    Trial Locations
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Glacier Oncology PLLC
    Kalispell, Montana 59901
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Lymphoma
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Kalispell Medical Oncology at KRMC
    Kalispell, Montana 59901
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    Glacier Oncology, PLLC

    Trial Locations
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Lung Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Kalispell Medical Oncology

    Trial Locations
    Kalispell Medical Oncology
    Kalispell Regional Medical Center
    Glacier Oncology PLLC
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Glacier Oncology PLLC
    Kalispell, Montana 59901
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Leukemia
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Glacier Oncology PLLC
    Kalispell, Montana 59901
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Liver Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Kalispell Medical Oncology at KRMC
    Kalispell, Montana 59901
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Kalispell Regional Medical Center
    Kalispell, Montana 59901
    Brain and Central Nervous System Tumors
    S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    Kalispell Regional Medical Center
    Kalispell, Montana 59901
    Brain and Central Nervous System Tumors
    S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
    Kalispell Regional Medical Center

    Trial Locations
    Kalispell Regional Medical Center
    Glacier Oncology, PLLC
    Kalispell Medical Oncology at KRMC
    Multiple Myeloma, Plasma Cell Myeloma, Precancerous Condition